Latest news
https://amr-accelerator.eu/wp-content/uploads/2023/11/AMR-Accelerator_square-3.png
4000
5000
Clément Robijns
https://amr-accelerator.eu/wp-content/uploads/2021/02/IMI-AMR-Accelerator_Slogan_horizontal_RGB.png
Clément Robijns2024-04-11 16:21:502024-04-21 10:29:1111/04/24 – WATCH NOW: RECORDING OF COMBINE WEBINAR ON DEVELOPING TARGET PRODUCT PROFILES FOR ANTIBIOTICS
https://amr-accelerator.eu/wp-content/uploads/2021/03/IMI-AMR-Accelerator_Slogan_square_RGB.png
1024
1339
Clément Robijns
https://amr-accelerator.eu/wp-content/uploads/2021/02/IMI-AMR-Accelerator_Slogan_horizontal_RGB.png
Clément Robijns2024-04-09 09:58:352024-04-21 10:29:2709/04/24 – AMR ACCELERATOR PARTNERS CELEBRATE COMPLETED PROJECTS AND DEMONSTRATE THE CONTINUED NEED FOR COLLABORATIVE EFFORTS IN AMR
https://amr-accelerator.eu/wp-content/uploads/2021/12/PRIMAVERA_News_5000x4000px.png
4000
5000
Clément Robijns
https://amr-accelerator.eu/wp-content/uploads/2021/02/IMI-AMR-Accelerator_Slogan_horizontal_RGB.png
Clément Robijns2024-03-15 10:47:112024-03-15 10:47:1108/03/24 – PrIMAVeRa participates in AMR Accelerator Cross-Project Meeting 2024
https://amr-accelerator.eu/wp-content/uploads/2021/12/TRiC_TB_News_5000x4000px.png
4000
5000
Clément Robijns
https://amr-accelerator.eu/wp-content/uploads/2021/02/IMI-AMR-Accelerator_Slogan_horizontal_RGB.png
Clément Robijns2024-03-05 09:00:582024-03-04 19:38:4305/03/24 – BioVersys and GSK Successfully Complete IMI2 Programme Reaching Clinical Milestone
https://amr-accelerator.eu/wp-content/uploads/2021/12/ERA4TB_News_5000x4000px.png
4000
5000
Clément Robijns
https://amr-accelerator.eu/wp-content/uploads/2021/02/IMI-AMR-Accelerator_Slogan_horizontal_RGB.png
Clément Robijns2024-02-15 13:11:242024-02-15 13:11:2412/02/24 – ERA4TB researcher wins award for innovative research design
https://amr-accelerator.eu/wp-content/uploads/2021/12/ERA4TB_News_5000x4000px.png
4000
5000
Clément Robijns
https://amr-accelerator.eu/wp-content/uploads/2021/02/IMI-AMR-Accelerator_Slogan_horizontal_RGB.png
Clément Robijns2024-02-01 13:42:322024-02-01 13:42:3225/01/24 – Public launch of TB-Platform for the Aggregation of Preclinical Experiments Data (TB-APEX)From the partners
https://amr-accelerator.eu/wp-content/uploads/2021/10/BEAM-Alliance.png
2000
2000
Clément Robijns
https://amr-accelerator.eu/wp-content/uploads/2021/02/IMI-AMR-Accelerator_Slogan_horizontal_RGB.png
Clément Robijns2021-10-21 13:32:402023-07-28 14:55:5121/10/21 – How the EU Pharmaceutical Strategy could help prevent the next pandemic
https://amr-accelerator.eu/wp-content/uploads/2021/08/DZIF.png
2000
2000
Clément Robijns
https://amr-accelerator.eu/wp-content/uploads/2021/02/IMI-AMR-Accelerator_Slogan_horizontal_RGB.png
Clément Robijns2021-08-25 13:30:282023-07-28 14:56:2425/08/21 – INCATE supports the fight against antibiotic-resistant bacteria
https://amr-accelerator.eu/wp-content/uploads/2021/04/BioVersys.png
2000
2000
Clément Robijns
https://amr-accelerator.eu/wp-content/uploads/2021/02/IMI-AMR-Accelerator_Slogan_horizontal_RGB.png
Clément Robijns2021-04-14 13:18:432023-07-28 14:57:3214/04/21 – BioVersys receives €20 million in EU financing to support development of new antibiotics
https://amr-accelerator.eu/wp-content/uploads/2021/03/TB-Alliance.png
2000
2000
Clément Robijns
https://amr-accelerator.eu/wp-content/uploads/2021/02/IMI-AMR-Accelerator_Slogan_horizontal_RGB.png
Clément Robijns2021-03-30 13:09:502023-07-28 14:58:1030/03/21 – Astellas and TB Alliance Enter into a New Collaborative Research Agreement to Identify Lead Compounds for the Treatment of Tuberculosis
https://amr-accelerator.eu/wp-content/uploads/2021/02/BIOASTER.png
2000
2000
Clément Robijns
https://amr-accelerator.eu/wp-content/uploads/2021/02/IMI-AMR-Accelerator_Slogan_horizontal_RGB.png
Clément Robijns2021-02-18 13:15:522023-07-28 14:58:4618/02/21 – Antimicrobials Program Highlights 2020
INTERVIEW WITH RESPIRITB & RESPIRINTM PROJECT COORDINATOR
INTERVIEW WITH IHI EXECUTIVE DIRECTOR AD INTERIM
INTERVIEW WITH PRIMAVERA PROJECT COORDINATOR
INTERVIEW WITH ALMARI CONRADIE FROM ERA4TB PROJECT